Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.66 |
| ▸ | HTR2C | P28335 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8948076 | 0.95 | HTR1A (0.64) | HTR1AHTR2CCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8947985 | 0.91 | KDM4E (0.58) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8948062 | 0.89 | HTR1A (0.69) | HTR1AHTR2CSIGMAR1 | |
| SCHEMBL8947779 | 0.88 | KDM4E (0.54) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8948104 | 0.86 | HTR2A (0.52) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8948011 | 0.85 | HTR1A (0.60) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8947994 | 0.84 | CYP1A2 (0.51) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8948074 | 0.84 | HTR1A (0.53) | HTR1AHTR2CKDM4ECYP1A2CYP3A4 | |
| SCHEMBL8948078 | 0.84 | HTR2A (0.55) | HTR2CKDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8948101 | 0.83 | TMEM97 (0.49) | HTR1ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5387586-A | Analgesics, nervous system disorders | ADIR ET COMPAGNIE (FR) | 1995-02-07 | — | — | US | claimed |
| US-5534517-A | (Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the treatment of anxiety and depression | ADIR ET COMPAGNIE (FR) | 1996-07-09 | — | — | US | disclosed |
| US-5387586-A | Analgesics, nervous system disorders | ADIR ET COMPAGNIE (FR) | 1995-02-07 | — | — | US | disclosed |
| EP-0613898-A1 | Aryl or arylalkyl-carbonyl heterocyclic derivatives, processes for their preparation and compositions containing them | ADIR ET COMPAGNIE (FR) | 1994-09-07 | — | — | EP | disclosed |